Telomere length in circulating lymphocytes: Association with chromosomal aberrations
2014; Wiley; Volume: 54; Issue: 3 Linguagem: Inglês
10.1002/gcc.22225
ISSN1098-2264
Autores Tópico(s)Immunotherapy and Immune Responses
ResumoGenes, Chromosomes and CancerVolume 54, Issue 3 p. 194-196 Letter to the Editor Telomere length in circulating lymphocytes: Association with chromosomal aberrations Kari Hemminki, Corresponding Author Kari Hemminki Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg, (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, Germany Center for Primary Health Care Research, Lund University, Malmö, SwedenCorrespondence to: Kari Hemminki; Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, Germany. E-mail: k.hemminki@dkfzSearch for more papers by this authorRachakonda Sivaramakrishna, Rachakonda Sivaramakrishna Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg, (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, GermanySearch for more papers by this authorMusak Ludovit, Musak Ludovit Clinic of Occupational Medicine and Toxicology, Jessenius Faculty of Medicine in Martin, Comenius, University in Bratislava and University Hospital Martin, Kollarova 2, 03601 Martin, SlovakiaSearch for more papers by this authorVymetalkova Veronika, Vymetalkova Veronika Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska, 1083 142 00 Prague, Czech Republic Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Albertov 4, 128 00 Prague, Czech RepublicSearch for more papers by this authorHalasova Erika, Halasova Erika Department of Medical Biology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, 03601 Martin, SlovakiaSearch for more papers by this authorFörsti Asta, Försti Asta Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg, (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, Germany Center for Primary Health Care Research, Lund University, Malmö, SwedenSearch for more papers by this authorVodickova Ludmila, Vodickova Ludmila Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska, 1083 142 00 Prague, Czech Republic Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Albertov 4, 128 00 Prague, Czech RepublicSearch for more papers by this authorBuchancova Janka, Buchancova Janka Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Sklabinska 26, 03601 Martin, SlovakiaSearch for more papers by this authorVodicka Pavel, Vodicka Pavel Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska, 1083 142 00 Prague, Czech Republic Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Albertov 4, 128 00 Prague, Czech RepublicSearch for more papers by this authorKumar Rajiv, Kumar Rajiv Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg, (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, GermanySearch for more papers by this author Kari Hemminki, Corresponding Author Kari Hemminki Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg, (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, Germany Center for Primary Health Care Research, Lund University, Malmö, SwedenCorrespondence to: Kari Hemminki; Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, Germany. E-mail: k.hemminki@dkfzSearch for more papers by this authorRachakonda Sivaramakrishna, Rachakonda Sivaramakrishna Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg, (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, GermanySearch for more papers by this authorMusak Ludovit, Musak Ludovit Clinic of Occupational Medicine and Toxicology, Jessenius Faculty of Medicine in Martin, Comenius, University in Bratislava and University Hospital Martin, Kollarova 2, 03601 Martin, SlovakiaSearch for more papers by this authorVymetalkova Veronika, Vymetalkova Veronika Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska, 1083 142 00 Prague, Czech Republic Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Albertov 4, 128 00 Prague, Czech RepublicSearch for more papers by this authorHalasova Erika, Halasova Erika Department of Medical Biology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, 03601 Martin, SlovakiaSearch for more papers by this authorFörsti Asta, Försti Asta Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg, (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, Germany Center for Primary Health Care Research, Lund University, Malmö, SwedenSearch for more papers by this authorVodickova Ludmila, Vodickova Ludmila Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska, 1083 142 00 Prague, Czech Republic Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Albertov 4, 128 00 Prague, Czech RepublicSearch for more papers by this authorBuchancova Janka, Buchancova Janka Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Sklabinska 26, 03601 Martin, SlovakiaSearch for more papers by this authorVodicka Pavel, Vodicka Pavel Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska, 1083 142 00 Prague, Czech Republic Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Albertov 4, 128 00 Prague, Czech RepublicSearch for more papers by this authorKumar Rajiv, Kumar Rajiv Department of Molecular Genetic Epidemiology, German Cancer Research Center Heidelberg, (DKFZ), Im Neuenheimer Feld 580, 69121 Heidelberg, GermanySearch for more papers by this author First published: 27 November 2014 https://doi.org/10.1002/gcc.22225Citations: 12Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DE, Tice R, Waters MD, Aitio A. 2000. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat Res 463: 111–172. 10.1016/S1383-5742(00)00049-1 CASPubMedWeb of Science®Google Scholar Artandi SE, DePinho RA. 2010. Telomeres and telomerase in cancer. Carcinogenesis 31: 9–18. 10.1093/carcin/bgp268 CASPubMedWeb of Science®Google Scholar Bonassi S, Norppa H, Ceppi M, Stromberg U, Vermeulen R, Znaor A, Cebulska-Wasilewska A, Fabianova E, Fucic A, Gundy S, Hansteen IL, Knudsen LE, Lazutka J, Rossner P, Sram RJ, Boffetta P. 2008. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: Results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis 29: 1178–1183. 10.1093/carcin/bgn075 CASPubMedWeb of Science®Google Scholar Cawthon RM. 2009. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37: e21. 10.1093/nar/gkn1027 CASPubMedWeb of Science®Google Scholar Durante M, Bedford JS, Chen DJ, Conrad S, Cornforth MN, Natarajan AT, van Gent DC, Obe G. 2013. From DNA damage to chromosome aberrations: Joining the break. Mutat Res 756: 5–13. 10.1016/j.mrgentox.2013.05.014 CASPubMedWeb of Science®Google Scholar Gostissa M, Alt FW, Chiarle R. 2011. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu Rev Immunol 29: 319–350. 10.1146/annurev-immunol-031210-101329 CASPubMedWeb of Science®Google Scholar Hemminki K, Musak L, Vymetalkova V, Smerhovsky Z, Halasova E, Osina O, Letkova L, Forsti A, Vodickova L, Buchancova J, Vodicka P. 2014. Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans. Leukemia 28: 721–722. 10.1038/leu.2013.353 CASPubMedWeb of Science®Google Scholar Jones CH, Pepper C, Baird DM. 2012. Telomere dysfunction and its role in haematological cancer. Br J Haematol 156: 573–587. 10.1111/j.1365-2141.2011.09022.x CASPubMedWeb of Science®Google Scholar Li H, Hilmarsen HT, Hossain MB, Bjork J, Hansteen IL, Albin M, Furu Skjelbred C, Broberg K. 2013. Telomere length and LINE1 methylation is associated with chromosomal aberrations in peripheral blood. Genes Chromosomes Cancer 52: 1–10. 10.1002/gcc.22000 CASPubMedWeb of Science®Google Scholar Mitelman F, Johansson B, Mertens F. 2007. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7: 233–245. 10.1038/nrc2091 CASPubMedWeb of Science®Google Scholar Musak L, Smerhovsky Z, Halasova E, Osina O, Letkova L, Vodickova L, Polakova V, Buchancova J, Hemminki K, Vodicka P. 2013. Chromosomal damage among medical staff occupationally exposed to volatile anesthetics, antineoplastic drugs, and formaldehyde. Scand J Work Environ Health 39: 618–30. 10.5271/sjweh.3358 CASPubMedWeb of Science®Google Scholar Shen M, Cawthon R, Rothman N, Weinstein SJ, Virtamo J, Hosgood HD, 3rd, Hu W, Lim U, Albanes D, Lan Q. 2011. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer 73: 133–137. 10.1016/j.lungcan.2010.11.009 PubMedWeb of Science®Google Scholar Vodicka P, Naccarati A, Vodickova L, Polakova V, Dusinska M, Musak L, Halasova E, Susova S, Soucek P, Hemminki K. 2009. Do GST polymorphisms modulate the frequency of chromosomal aberrations in healthy subjects? Environ Health Perspect 117: A384–A385. 10.1289/ehp.0900838 PubMedWeb of Science®Google Scholar Vodicka P, Polivkova Z, Sytarova S, Demova H, Kucerova M, Vodickova L, Polakova V, Naccarati A, Smerhovsky Z, Ambrus M, Cerna M, Hemminki K. 2010. Chromosomal damage in peripheral blood lymphocytes of newly diagnosed cancer patients and healthy controls. Carcinogenesis 31: 1238–1241. 10.1093/carcin/bgq056 CASPubMedWeb of Science®Google Scholar Xu L, Li S, Stohr BA. 2013. The role of telomere biology in cancer. Annu Rev Pathol 8: 49–78. 10.1146/annurev-pathol-020712-164030 CASPubMedWeb of Science®Google Scholar Citing Literature Volume54, Issue3March 2015Pages 194-196 ReferencesRelatedInformation
Referência(s)